Phenobarbitone in essential tremor
- 1 December 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 35 (12), 1784
- https://doi.org/10.1212/wnl.35.12.1784
Abstract
We conducted a double-blind, placebo-controlled trial of phenobarbitone on a fixed-dose regimen in 12 patients with essential tremor. The drug was better than placebo on accelerometric measurement and clinical assessment, but not according to patient self-assessment or measures of manual performance. Phenobarbitone may be an alternative to beta-adrenoreceptor antagonists in treating essential tremor.This publication has 6 references indexed in Scilit:
- The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- Phenobarbital and propranolol in essential tremorNeurology, 1983
- Phenylethylmalonamide in essential tremor. A double-blind controlled study.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Benign familial tremor treated with primidone.BMJ, 1981
- beta-Adrenoreceptor antagonists in essential tremor.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- PHENOBARBITAL - STUDIES OF ELIMINATION, ACCUMULATION, TOLERANCE, AND DOSAGE SCHEDULES1954